Description
The Office of Minority Health (OMH) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of Section 1707 of the Public Health Service Act (42 U.S.C. § 300u-6). This notice solicits applications for projects to implement integrated, community-based models that increase participation of underrepresented populations in lupus clinical trials across the full participation pathway, including awareness, referral, screening, enrollment, and retention. The primary focus of the grants is to reduce lupus-related adverse health outcomes by increasing participation of underrepresented populations in lupus clinical trials. The program will support outreach, education, and partnerships that move beyond awareness building to measurable participation outcomes, including screening, enrollment, and retention in lupus clinical trials. Some key expectations for recipients include building and sustaining trusted community partnerships, adapting evidence-informed practices, demonstrating increased enrollment in lupus clinical trials, implementing a process and outcomes evaluation, and documenting and disseminating project findings.
• Implementing a Quality Improvement and Quality Assurance (QI/QA) Plan
• Utilizing standard practices for establishing and sustaining effective collaborative partnerships
• Leveraging the strengths of each partner organization
• Implementing a project that involves at least two collaborative partnerships with at least two different organizations
• Having an established relationship with a lupus clinical trial site or having a plan to establish a relationship with a lupus clinical trial site by the end of the first quarter of the award period